Annual report pursuant to Section 13 and 15(d)

Significant Transactions (Narrative) (Details)

v3.23.3
Significant Transactions (Narrative) (Details)
 3 Months Ended 12 Months Ended
Sep. 19, 2022
shares
Sep. 16, 2022
USD ($)
shares
Nov. 01, 2021
USD ($)
lease
$ / shares
shares
Aug. 23, 2021
USD ($)
shares
Dec. 31, 2022
USD ($)
Jun. 30, 2023
USD ($)
item
Jun. 30, 2022
USD ($)
Impairment of investment in equity security             $ 1,760,000
General and administrative expenses           $ 19,016,000 21,754,000
Value of common stock issued           20,000 9,000
Accrued expenses           1,100,000  
Accrued expenses - noncurrent           527,000  
Secured Term Loan              
Secured term loan     $ 22,375,000     13,057,000 22,375,000
Interest rate (as percent)     3.25%        
Cost incurred to attain debt           $ 120,000 214,000
RubrYc Therapeutics, Inc. [Member]              
Total purchase price   $ 1,000,000          
Fair market value of property   650,000          
Amount advanced   484,000          
Transaction costs   208,000          
Finance leases   $ 814,000 $ 814,000        
Stock purchase agreement, number of shares purchased | shares   102,354          
Liability for the assumed acquisition   $ 5,000,000          
Impairment of current prepaid expense             288,000
Impairment of non-current prepaid expense             $ 864,000
Number of shares issued | shares 102,354            
Number of equipment leases | lease     3        
College Station Investors LLC And Bryan Capital [Member]              
Total purchase price     $ 28,750,000        
Cash payment     28,000,000        
Fair market value of property     $ 151,450        
Percentage of base rent     6.50%        
Cash consideration for equity interest acquired     $ 50,000        
Number of warrants issued | shares     51,583        
Warrants, exercise price per share | $ / shares     $ 33.25        
Shares issued under the Warrant | shares     11,583        
Fair value of the warrant     $ 217,255        
College Station Investors LLC And Bryan Capital [Member] | Secured Term Loan              
Secured term loan     $ 22,375,000        
College Station Investors LLC And Bryan Capital [Member] | IBio CMO Preferred Tracking Stock              
Warrants issuable | shares     1        
Percentage of equity interest     0.01%        
Separation Agreement and General Release [Member]              
General and administrative expenses         $ 2,130,000    
Period of bi-monthly installments of current base salary           24 months  
Period of bi-monthly installments of target bonus           24 months  
Maximum period for coverage of health insurance           18 months  
COBRA subsidy period           18 months  
Number of times on which lump sum cash payment tis o be made | item           6  
Accrued expenses - noncurrent           $ 527,000  
Collaboration, Option and License Agreement [Member] | Immune-Oncology Antibodies (RTX-003) [Member] | RubrYc Therapeutics, Inc. [Member]              
Collaboration and license agreement, agreement term       5 years      
Collaboration, Option and License Agreement [Member] | Immune-Oncology Antibodies (RTX-003) [Member] | No Biosimilar Product has been Approved [Member] | RubrYc Therapeutics, Inc. [Member]              
Collaboration and license agreement, royalty payment term       10 years      
Series A-2 Preferred Stock [Member] | Stock Purchase Agreement [Member] | Immune-Oncology Antibodies (RTX-003) [Member] | RubrYc Therapeutics, Inc. [Member]              
Stock purchase agreement, number of shares purchased | shares       2,864,345      
Stock purchase agreement, value of shares purchased       $ 7,500,000